Related Experiment Video
Updated: May 8, 2026
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Genetic cardiomyopathies causing heart failure.
Thomas J Cahill1, Houman Ashrafian, Hugh Watkins
1Department of Cardiovascular Medicine, University of Oxford, UK.
Circulation Research
|August 31, 2013
Summary
Genetic factors significantly influence heart failure (HF) risk and progression. Understanding these complex genetic underpinnings, from rare mutations to common variants, is crucial for developing new diagnostics and therapies for HF.
Area of Science:
- Cardiology
- Genetics
- Genomics
Background:
- Heart failure (HF) poses a significant global health burden despite medical advances.
- Genetic predisposition plays a complex and heterogeneous role in HF development and prognosis.
- Familial cardiomyopathies represent a spectrum from rare monogenic forms to complex polygenic influences.
Purpose of the Study:
- To review the current understanding of genetic contributions to heart failure.
- To highlight the challenges and opportunities in genetic research for HF.
- To discuss the implications for diagnostics and therapeutic strategies.
Main Methods:
- Review of existing literature on genetic heart failure syndromes and cardiomyopathies.
- Analysis of data from sequencing technologies and genetic variation annotation.
- Emphasis on pedigree analysis and clinical phenotyping.
Main Results:
- Monogenic HF syndromes offer insights into disease mechanisms, diagnostics, and therapies.
- Common genetic variants contribute to HF susceptibility and course.
- Distinguishing pathogenic mutations from benign variants is a key challenge.
Conclusions:
- Genetic research is advancing understanding of distinct HF subtypes.
- Novel sequencing technologies generate vast amounts of data requiring careful interpretation.
- Integrated approaches combining genetics, phenotyping, and bioinformatics are essential for future progress in HF management.
Related Concept Videos
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...